Medication Monitor



Generic Name (Trade Name—Company)
Notes
June 1, 2017

Dietary supplement

(GEC Laxoplex—Genetic Edge Compounds)
Recalled dietary supplement for muscle enhancement contains anabolic steroids

Genetic Edge Compounds is voluntarily recalling all lot codes of GEC Laxoplex dietary supplement capsules distributed between February 2, 2015, and May 2, 2017. The supplements, packaged in a white plastic bottle containing 60 capsules, are marketed as a muscle-enhancing agent.

FDA analysis has found GEC Laxoplex to be tainted with anabolic steroids and steroid-like substances, rendering the supplement an unapproved drug for which safety and efficacy have not been established.

Use or consumption of products containing anabolic steroids may cause acute liver injury, which is known to be a possible harmful effect of using steroid-containing products. In addition, abuse of anabolic steroids may cause other serious long-term adverse health consequences in men, women, and children. These include shrinkage of the testes and male infertility, masculinization of women, breast enlargement in males, short stature in children, a higher predilection to misuse other drugs and alcohol, adverse effects on blood lipid levels, and increased risk of heart attack, stroke, and death. 

To date, Genetic Edge Compounds has not received any reports of these or any other adverse effects related to this recall.

The recall affects all lots of GEC Laxoplex that were distributed nationwide through various nutritional supplement retail outlets.